CD8+ T cell responses play an important role in the control of HIV-1. The extensive sequence diversity of HIV-1 represents a critical hurdle to developing an effective HIV-1 vaccine, and it is likely that regional-specific vaccine strains will be required to overcome the diversity of the different HIV-1 clades distributed world-wide. Unfortunately, little is known about the CD8+ T cell responses against CRF01_AE, which is responsible for the majority of infections in Southeast Asia.To identify dominant CD8+ T cell responses recognized in HIV-1 clade CRF01_AE infected subjects we drew upon data from an immunological screen of 100 HIV-1 clade CRF01_AE infected subjects using IFN-gamma ELISpot to characterize a novel immunodominant CD8+ T cell...
To date, 11 HIV-1 subtypes and 48 circulating recombinant forms have been described worldwide. The u...
Background Fine definition of targeted CD8+ T-cell epitopes and their human leucocyte antigen (HLA)...
Objectives: Human Leukocyte Antigen HLA-B*57:01 and B*58:01 are considered anti-HIV-1 protective all...
BACKGROUND: CD8+ T cell responses play an important role in the control of HIV-1. The extensive sequ...
Background: CD8+ T cell responses play an important role in the control of HIV-1. The extensive sequ...
CD8+ T cell responses play an important role in the control of HIV-1. The extensive sequence diversi...
Background: CD8+ T cell responses play an important role in the control of HIV-1. The extensive sequ...
<div><h3>Introduction</h3><p>The design of a globally effective vaccine rests on the identification ...
Introduction: The design of a globally effective vaccine rests on the identification of epitopes cap...
The design of a globally effective vaccine rests on the identification of epitopes capable of elicit...
Thesis (Ph.D.)--University of Washington, 2012The enormity of global human immunodeficiency virus ty...
Background Fine definition of targeted CD8+ T-cell epitopes and their human leucocyte antigen (HLA)...
BackgroundFine definition of targeted CD8+ T-cell epitopes and their human leucocyte antigen (HLA) c...
To date, 11 HIV-1 subtypes and 48 circulating recombinant forms have been described worldwide. The u...
Introduction: The design of a globally effective vaccine rests on the identification of epitopes cap...
To date, 11 HIV-1 subtypes and 48 circulating recombinant forms have been described worldwide. The u...
Background Fine definition of targeted CD8+ T-cell epitopes and their human leucocyte antigen (HLA)...
Objectives: Human Leukocyte Antigen HLA-B*57:01 and B*58:01 are considered anti-HIV-1 protective all...
BACKGROUND: CD8+ T cell responses play an important role in the control of HIV-1. The extensive sequ...
Background: CD8+ T cell responses play an important role in the control of HIV-1. The extensive sequ...
CD8+ T cell responses play an important role in the control of HIV-1. The extensive sequence diversi...
Background: CD8+ T cell responses play an important role in the control of HIV-1. The extensive sequ...
<div><h3>Introduction</h3><p>The design of a globally effective vaccine rests on the identification ...
Introduction: The design of a globally effective vaccine rests on the identification of epitopes cap...
The design of a globally effective vaccine rests on the identification of epitopes capable of elicit...
Thesis (Ph.D.)--University of Washington, 2012The enormity of global human immunodeficiency virus ty...
Background Fine definition of targeted CD8+ T-cell epitopes and their human leucocyte antigen (HLA)...
BackgroundFine definition of targeted CD8+ T-cell epitopes and their human leucocyte antigen (HLA) c...
To date, 11 HIV-1 subtypes and 48 circulating recombinant forms have been described worldwide. The u...
Introduction: The design of a globally effective vaccine rests on the identification of epitopes cap...
To date, 11 HIV-1 subtypes and 48 circulating recombinant forms have been described worldwide. The u...
Background Fine definition of targeted CD8+ T-cell epitopes and their human leucocyte antigen (HLA)...
Objectives: Human Leukocyte Antigen HLA-B*57:01 and B*58:01 are considered anti-HIV-1 protective all...